Respiratory Disorders Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
Renaud Louis, University of Liège, CHU Sart-Tilman, Belgium. F1000 Respiratory Disorders
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
4 Recommendations, most recent by
Teal Hallstrand, University of Washington, USA. F1000 Respiratory Disorders
- Controversial
- Interesting Hypothesis
- New Finding
- Novel Drug Target
Past 7 Days
15
New Recommendations
6,226 total
11
New Articles Recommended
3,915 total
Past 30 Days
-
13Articles Classified As Controversial448 total
-
5Articles Classified As Novel Drug Target106 total
-
6Articles Classified As Review / Commentary246 total
-
23Articles Classified As Confirmation1,718 total
-
3Articles Classified As Technical Advance334 total
-
51Articles Classified As New Finding2,883 total
-
15Articles Classified As Interesting Hypothesis765 total
-
22Articles Classified As Good for Teaching175 total
-
2Articles Classified As Refutation94 total
-
14Articles Classified As Clinical Trial1,562 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

